Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Innovation/
  4. About the Johnson & Johnson Women in STEM²D Scholars Award Program

About the Johnson & Johnson Women in STEM²D Scholars Award Program

WiSTEM microscope

The Johnson & Johnson Scholars Award Program aims to fuel the development of female STEM2D leaders and feed the STEM2D talent pipeline by awarding and sponsoring women at critical points in their research careers, in each of the STEM2D disciplines: Science, Technology, Engineering, Math, Manufacturing and Design.

The awards will fund one woman per discipline who has completed her advanced degree, who is working as an assistant professor or global equivalent and who is not yet tenured at an accredited university or design institution. The goal is to fuel the research passion of the awarded women and inspire career paths in their respective STEM2D fields.

By offering these awards, Johnson & Johnson hopes to play an influential role in STEM2D breakthroughs in the future.

WiSTEM2D Scholars Award

The Johnson & Johnson WiSTEM²D Scholars Award Program will help develop female leaders and support innovation in STEM fields.

More from Johnson & Johnson

What is head and neck cancer?

This complex type of cancer can cause malignancies of the mouth, throat, larynx and nasal cavity. Find out how Johnson & Johnson is innovating to change the current treatment paradigm.

5 things we now know about atrial fibrillation

More than 50 million people worldwide are affected by this common type of heart arrhythmia. Learn the facts behind this heart condition, plus one patient’s diagnosis story.

Shockwave: Inside the development of a cutting-edge system to treat coronary artery disease

Johnson & Johnson’s Patrick Stephens explains how innovative technology using ultrasonic acoustic pressure waves has made the treatment of certain types of cardiovascular disease easier for doctors and safer for patients.